APO Research

APO RESEARCH · REPORT

Transcranial Magnetic Stimulators (TMS)

Transcranial magnetic stimulation (TMS) is a magnetic method used to stimulate small regions of the brain. During a TMS procedure, a magnetic field generator, or "coil", is placed near the head of the person receiving the Tinnitus. The coil produces small electric currents in the region of the brain just under the coil via electromagnetic induction. The coil is connected to a pulse generator, or stimulator, that delivers electric current to the coil.

Product & engineering

Understand the product.

Transcranial magnetic stimulation (TMS) is a magnetic method used to stimulate small regions of the brain. During a TMS procedure, a magnetic field generator, or "coil", is placed near the head of the person receiving the Tinnitus. The coil produces small electric currents in the region of the brain just under the coil via electromagnetic induction. The coil is connected to a pulse generator, or stimulator, that delivers electric current to the coil.

TMS is used diagnostically to measure the connection between the brain and a muscle to evaluate damage from stroke, multiple sclerosis, amyotrophic lateral sclerosis, movement disorders, motor neuron disease, and injuries and other disorders affecting the facial and other cranial nerves and the spinal cord.

Selected research

Market Outlook & Growth Opportunities

Global Transcranial Magnetic Stimulators (TMS) Market Outlook and Growth Opportunities 2026

Market perspective

Transcranial magnetic stimulation (TMS) is a magnetic method used to stimulate small regions of the brain. During a TMS procedure, a magnetic field generator, or "coil", is placed near the head of the person receiving the Tinnitus. The coil produces small electric currents in the region of the brain just under the coil via electromagnetic induction. The coil is connected to a pulse generator, or stimulator, that delivers electric current to the coil.

TMS is used diagnostically to measure the connection between the brain and a muscle to evaluate damage from stroke, multiple sclerosis, amyotrophic lateral sclerosis, movement disorders, motor neuron disease, and injuries and other disorders affecting the facial and other cranial nerves and the spinal cord.

The main consumption market for TMS is China, accounting for about 50% of the market, followed by Europe, accounting for about 25%.

Read the full market overview

Leading vendors include Yiruide, Neuronetics, Magstim, Brainsway, MagVenture, and Eneura, with the top 5 accounting for about 63% of the market.

This report provides an overview of the global Transcranial Magnetic Stimulators (TMS) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Transcranial Magnetic Stimulators (TMS) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Transcranial Magnetic Stimulators (TMS) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Transcranial Magnetic Stimulators (TMS) market size, projected growth trends, production technologies, key applications, and end-use industries.

Transcranial Magnetic Stimulators (TMS) Segment by Company

Yiruide

Neuronetics

Magstim

Brainsway

MagVenture

eNeura

Remed

Neurosoft

Dr. Langer Medical

Nexstim

MAG & More

EB Neuro

Jiangxi Brain Modulate Technology Development Co., LTD

VISHEE

YINGCHI

Sichuan Junjian Wanfeng Medical Devices Co., Ltd.

Transcranial Magnetic Stimulators (TMS) Segment by Type

sTMS

pTMS

rTMS

Transcranial Magnetic Stimulators (TMS) Segment by Application

Psychopharmacology

Neurology

Rehabilitation Department

Others

Transcranial Magnetic Stimulators (TMS) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Transcranial Magnetic Stimulators (TMS) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Transcranial Magnetic Stimulators (TMS) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Transcranial Magnetic Stimulators (TMS) significant trends, drivers, influence factors in global and regions.

6. To analyze Transcranial Magnetic Stimulators (TMS) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transcranial Magnetic Stimulators (TMS) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Transcranial Magnetic Stimulators (TMS) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transcranial Magnetic Stimulators (TMS).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Transcranial Magnetic Stimulators (TMS) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Transcranial Magnetic Stimulators (TMS) industry.

Chapter 3: Detailed analysis of Transcranial Magnetic Stimulators (TMS) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Transcranial Magnetic Stimulators (TMS) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Transcranial Magnetic Stimulators (TMS) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Transcranial Magnetic Stimulators (TMS) Industry Trends Table 2. Transcranial Magnetic Stimulators (TMS) Industry Drivers Table 3. Transcranial Magnetic Stimulators (TMS) Industry Opportunities and Challenges Table 4. Transcranial Magnetic Stimulators (TMS) Industry Restraints Table 5. Global Transcranial Magnetic Stimulators (TMS) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Transcranial Magnetic Stimulators (TMS) Revenue Share by Company (2021-2026) Table 7. Global Transcranial Magnetic Stimulators (TMS) Sales Volume by Company (Units) & (2021-2026) Table 8. Global Transcranial Magnetic Stimulators (TMS) Sales Volume Share by Company (2021-2026) Table 9. Global Transcranial Magnetic Stimulators (TMS) Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Transcranial Magnetic Stimulators (TMS) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Transcranial Magnetic Stimulators (TMS) Key Company Manufacturing Base & Headquarters Table 12. Global Transcranial Magnetic Stimulators (TMS) Company, Product Type & Application Table 13. Global Transcranial Magnetic Stimulators (TMS) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Transcranial Magnetic Stimulators (TMS) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of sTMS Table 18. Significant Companies of pTMS Table 19. Significant Companies of rTMS Table 20. Global Transcranial Magnetic Stimulators (TMS) Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 21. Global Transcranial Magnetic Stimulators (TMS) Sales Volume by Type (2021-2026) & (Units) Table 22. Global Transcranial Magnetic Stimulators (TMS) Sales Volume by Type (2027-2032) & (Units) Table 23. Global Transcranial Magnetic Stimulators (TMS) Sales Volume Share by Type (2021-2026) Table 24. Global Transcranial Magnetic Stimulators (TMS) Sales Volume Share by Type (2027-2032) Table 25. Global Transcranial Magnetic Stimulators (TMS) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Transcranial Magnetic Stimulators (TMS) Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Transcranial Magnetic Stimulators (TMS) Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type (2021-2026) Table 29. Global Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Psychopharmacology Table 31. Significant Companies of Neurology Table 32. Significant Companies of Rehabilitation Department Table 33. Significant Companies of Others Table 34. Global Transcranial Magnetic Stimulators (TMS) Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 35. Global Transcranial Magnetic Stimulators (TMS) Sales Volume by Application (2021-2026) & (Units) Table 36. Global Transcranial Magnetic Stimulators (TMS) Sales Volume by Application (2027-2032) & (Units) Table 37. Global Transcranial Magnetic Stimulators (TMS) Sales Volume Share by Application (2021-2026) Table 38. Global Transcranial Magnetic Stimulators (TMS) Sales Volume Share by Application (2027-2032) Table 39. Global Transcranial Magnetic Stimulators (TMS) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Transcranial Magnetic Stimulators (TMS) Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Transcranial Magnetic Stimulators (TMS) Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application (2021-2026) Table 43. Global Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application (2027-2032) Table 44. Global Transcranial Magnetic Stimulators (TMS) Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 45. Global Transcranial Magnetic Stimulators (TMS) Sales by Region (2021-2026) & (Units) Table 46. Global Transcranial Magnetic Stimulators (TMS) Sales Market Share by Region (2021-2026) Table 47. Global Transcranial Magnetic Stimulators (TMS) Sales by Region (2027-2032) & (Units) Table 48. Global Transcranial Magnetic Stimulators (TMS) Sales Market Share by Region (2027-2032) Table 49. Global Transcranial Magnetic Stimulators (TMS) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Transcranial Magnetic Stimulators (TMS) Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Transcranial Magnetic Stimulators (TMS) Sales Value Share by Region (2021-2026) Table 52. Global Transcranial Magnetic Stimulators (TMS) Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Transcranial Magnetic Stimulators (TMS) Sales Value Share by Region (2027-2032) Table 54. Global Transcranial Magnetic Stimulators (TMS) Market Average Price (USD/Unit) by Region (2021-2026) Table 55. Global Transcranial Magnetic Stimulators (TMS) Market Average Price (USD/Unit) by Region (2027-2032) Table 56. Global Transcranial Magnetic Stimulators (TMS) Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 57. Global Transcranial Magnetic Stimulators (TMS) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Transcranial Magnetic Stimulators (TMS) Sales by Country (2021-2026) & (Units) Table 59. Global Transcranial Magnetic Stimulators (TMS) Sales Market Share by Country (2021-2026) Table 60. Global Transcranial Magnetic Stimulators (TMS) Sales by Country (2027-2032) & (Units) Table 61. Global Transcranial Magnetic Stimulators (TMS) Sales Market Share by Country (2027-2032) Table 62. Global Transcranial Magnetic Stimulators (TMS) Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Transcranial Magnetic Stimulators (TMS) Sales Value Market Share by Country (2021-2026) Table 64. Global Transcranial Magnetic Stimulators (TMS) Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Transcranial Magnetic Stimulators (TMS) Sales Value Market Share by Country (2027-2032) Table 66. Yiruide Company Information Table 67. Yiruide Business Overview Table 68. Yiruide Transcranial Magnetic Stimulators (TMS) Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 69. Yiruide Transcranial Magnetic Stimulators (TMS) Product Portfolio Table 70. Yiruide Recent Development Table 71. Neuronetics Company Information Table 72. Neuronetics Business Overview Table 73. Neuronetics Transcranial Magnetic Stimulators (TMS) Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Neuronetics Transcranial Magnetic Stimulators (TMS) Product Portfolio Table 75. Neuronetics Recent Development Table 76. Magstim Company Information Table 77. Magstim Business Overview Table 78. Magstim Transcranial Magnetic Stimulators (TMS) Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Magstim Transcranial Magnetic Stimulators (TMS) Product Portfolio Table 80. Magstim Recent Development Table 81. Brainsway Company Information Table 82. Brainsway Business Overview Table 83. Brainsway Transcranial Magnetic Stimulators (TMS) Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Brainsway Transcranial Magnetic Stimulators (TMS) Product Portfolio Table 85. Brainsway Recent Development Table 86. MagVenture Company Information Table 87. MagVenture Business Overview Table 88. MagVenture Transcranial Magnetic Stimulators (TMS) Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. MagVenture Transcranial Magnetic Stimulators (TMS) Product Portfolio Table 90. MagVenture Recent Development Table 91. eNeura Company Information Table 92. eNeura Business Overview Table 93. eNeura Transcranial Magnetic Stimulators (TMS) Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. eNeura Transcranial Magnetic Stimulators (TMS) Product Portfolio Table 95. eNeura Recent Development Table 96. Remed Company Information Table 97. Remed Business Overview Table 98. Remed Transcranial Magnetic Stimulators (TMS) Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Remed Transcranial Magnetic Stimulators (TMS) Product Portfolio Table 100. Remed Recent Development Table 101. Neurosoft Company Information Table 102. Neurosoft Business Overview Table 103. Neurosoft Transcranial Magnetic Stimulators (TMS) Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Neurosoft Transcranial Magnetic Stimulators (TMS) Product Portfolio Table 105. Neurosoft Recent Development Table 106. Dr. Langer Medical Company Information Table 107. Dr. Langer Medical Business Overview Table 108. Dr. Langer Medical Transcranial Magnetic Stimulators (TMS) Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. Dr. Langer Medical Transcranial Magnetic Stimulators (TMS) Product Portfolio Table 110. Dr. Langer Medical Recent Development Table 111. Nexstim Company Information Table 112. Nexstim Business Overview Table 113. Nexstim Transcranial Magnetic Stimulators (TMS) Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. Nexstim Transcranial Magnetic Stimulators (TMS) Product Portfolio Table 115. Nexstim Recent Development Table 116. MAG & More Company Information Table 117. MAG & More Business Overview Table 118. MAG & More Transcranial Magnetic Stimulators (TMS) Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 119. MAG & More Transcranial Magnetic Stimulators (TMS) Product Portfolio Table 120. MAG & More Recent Development Table 121. EB Neuro Company Information Table 122. EB Neuro Business Overview Table 123. EB Neuro Transcranial Magnetic Stimulators (TMS) Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 124. EB Neuro Transcranial Magnetic Stimulators (TMS) Product Portfolio Table 125. EB Neuro Recent Development Table 126. Jiangxi Brain Modulate Technology Development Co., LTD Company Information Table 127. Jiangxi Brain Modulate Technology Development Co., LTD Business Overview Table 128. Jiangxi Brain Modulate Technology Development Co., LTD Transcranial Magnetic Stimulators (TMS) Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 129. Jiangxi Brain Modulate Technology Development Co., LTD Transcranial Magnetic Stimulators (TMS) Product Portfolio Table 130. Jiangxi Brain Modulate Technology Development Co., LTD Recent Development Table 131. VISHEE Company Information Table 132. VISHEE Business Overview Table 133. VISHEE Transcranial Magnetic Stimulators (TMS) Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 134. VISHEE Transcranial Magnetic Stimulators (TMS) Product Portfolio Table 135. VISHEE Recent Development Table 136. YINGCHI Company Information Table 137. YINGCHI Business Overview Table 138. YINGCHI Transcranial Magnetic Stimulators (TMS) Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 139. YINGCHI Transcranial Magnetic Stimulators (TMS) Product Portfolio Table 140. YINGCHI Recent Development Table 141. Sichuan Junjian Wanfeng Medical Devices Co., Ltd. Company Information Table 142. Sichuan Junjian Wanfeng Medical Devices Co., Ltd. Business Overview Table 143. Sichuan Junjian Wanfeng Medical Devices Co., Ltd. Transcranial Magnetic Stimulators (TMS) Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 144. Sichuan Junjian Wanfeng Medical Devices Co., Ltd. Transcranial Magnetic Stimulators (TMS) Product Portfolio Table 145. Sichuan Junjian Wanfeng Medical Devices Co., Ltd. Recent Development Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Transcranial Magnetic Stimulators (TMS) Distributors List Table 149. Transcranial Magnetic Stimulators (TMS) Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Transcranial Magnetic Stimulators (TMS) Product Image Figure 2. Global Transcranial Magnetic Stimulators (TMS) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Transcranial Magnetic Stimulators (TMS) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Transcranial Magnetic Stimulators (TMS) Sales (2021-2032) & (Units) Figure 5. Global Transcranial Magnetic Stimulators (TMS) Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Transcranial Magnetic Stimulators (TMS) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. sTMS Image Figure 10. pTMS Image Figure 11. rTMS Image Figure 12. Global Transcranial Magnetic Stimulators (TMS) Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 13. Global Transcranial Magnetic Stimulators (TMS) Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Transcranial Magnetic Stimulators (TMS) Sales Volume Share by Type (2021-2032) Figure 15. Global Transcranial Magnetic Stimulators (TMS) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Transcranial Magnetic Stimulators (TMS) Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type (2021-2032) Figure 18. Psychopharmacology Image Figure 19. Neurology Image Figure 20. Rehabilitation Department Image Figure 21. Others Image Figure 22. Global Transcranial Magnetic Stimulators (TMS) Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 23. Global Transcranial Magnetic Stimulators (TMS) Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Transcranial Magnetic Stimulators (TMS) Sales Volume Share by Application (2021-2032) Figure 25. Global Transcranial Magnetic Stimulators (TMS) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Transcranial Magnetic Stimulators (TMS) Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application (2021-2032) Figure 28. Global Transcranial Magnetic Stimulators (TMS) Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 29. Global Transcranial Magnetic Stimulators (TMS) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Transcranial Magnetic Stimulators (TMS) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Transcranial Magnetic Stimulators (TMS) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Transcranial Magnetic Stimulators (TMS) Sales Value (2021-2032) & (US$ Million) Figure 33. North America Transcranial Magnetic Stimulators (TMS) Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Transcranial Magnetic Stimulators (TMS) Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Transcranial Magnetic Stimulators (TMS) Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Transcranial Magnetic Stimulators (TMS) Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Transcranial Magnetic Stimulators (TMS) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Transcranial Magnetic Stimulators (TMS) Sales Value (2021-2032) & (US$ Million) Figure 39. South America Transcranial Magnetic Stimulators (TMS) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Transcranial Magnetic Stimulators (TMS) Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Transcranial Magnetic Stimulators (TMS) Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Transcranial Magnetic Stimulators (TMS) Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Transcranial Magnetic Stimulators (TMS) Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • sTMS
  • pTMS
  • rTMS
Applications
  • Psychopharmacology
  • Neurology
  • Rehabilitation Department
  • Others
Companies covered
  • Yiruide
  • Neuronetics
  • Magstim
  • Brainsway
  • MagVenture
  • eNeura
  • Remed
  • Neurosoft
  • Dr. Langer Medical
  • Nexstim
  • MAG & More
  • EB Neuro
  • Jiangxi Brain Modulate Technology Development Co., LTD
  • VISHEE
  • YINGCHI
  • Sichuan Junjian Wanfeng Medical Devices Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Transcranial Magnetic Stimulators (TMS) Sales Value (2021-2032)
  4. 1.2.2 Global Transcranial Magnetic Stimulators (TMS) Sales Volume (2021-2032)
  5. 1.2.3 Global Transcranial Magnetic Stimulators (TMS) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Transcranial Magnetic Stimulators (TMS) Market Dynamics
  1. 2.1 Transcranial Magnetic Stimulators (TMS) Industry Trends
  2. 2.2 Transcranial Magnetic Stimulators (TMS) Industry Drivers
  3. 2.3 Transcranial Magnetic Stimulators (TMS) Industry Opportunities and Challenges
  4. 2.4 Transcranial Magnetic Stimulators (TMS) Industry Restraints
3 Transcranial Magnetic Stimulators (TMS) Market by Company
  1. 3.1 Global Transcranial Magnetic Stimulators (TMS) Company Revenue Ranking in 2025
  2. 3.2 Global Transcranial Magnetic Stimulators (TMS) Revenue by Company (2021-2026)
  3. 3.3 Global Transcranial Magnetic Stimulators (TMS) Sales Volume by Company (2021-2026)
  4. 3.4 Global Transcranial Magnetic Stimulators (TMS) Average Price by Company (2021-2026)
  5. 3.5 Global Transcranial Magnetic Stimulators (TMS) Company Ranking (2024-2026)
  6. 3.6 Global Transcranial Magnetic Stimulators (TMS) Company Manufacturing Base and Headquarters
  7. 3.7 Global Transcranial Magnetic Stimulators (TMS) Company Product Type and Application
  8. 3.8 Global Transcranial Magnetic Stimulators (TMS) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Transcranial Magnetic Stimulators (TMS) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Transcranial Magnetic Stimulators (TMS) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Transcranial Magnetic Stimulators (TMS) Market by Type
  1. 4.1 Transcranial Magnetic Stimulators (TMS) Type Introduction
  2. 4.1.1 sTMS
  3. 4.1.2 pTMS
  4. 4.1.3 rTMS
  5. 4.2 Global Transcranial Magnetic Stimulators (TMS) Sales Volume by Type
  6. 4.2.1 Global Transcranial Magnetic Stimulators (TMS) Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Transcranial Magnetic Stimulators (TMS) Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Transcranial Magnetic Stimulators (TMS) Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Type
  10. 4.3.1 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Type (2021-2032)
  12. 4.3.3 Global Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type (2021-2032)
5 Transcranial Magnetic Stimulators (TMS) Market by Application
  1. 5.1 Transcranial Magnetic Stimulators (TMS) Application Introduction
  2. 5.1.1 Psychopharmacology
  3. 5.1.2 Neurology
  4. 5.1.3 Rehabilitation Department
  5. 5.1.4 Others
  6. 5.2 Global Transcranial Magnetic Stimulators (TMS) Sales Volume by Application
  7. 5.2.1 Global Transcranial Magnetic Stimulators (TMS) Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Transcranial Magnetic Stimulators (TMS) Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Transcranial Magnetic Stimulators (TMS) Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Application
  11. 5.3.1 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Application (2021-2032)
  13. 5.3.3 Global Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application (2021-2032)
6 Transcranial Magnetic Stimulators (TMS) Regional Sales and Value Analysis
  1. 6.1 Global Transcranial Magnetic Stimulators (TMS) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Transcranial Magnetic Stimulators (TMS) Sales by Region (2021-2032)
  3. 6.2.1 Global Transcranial Magnetic Stimulators (TMS) Sales by Region: 2021-2026
  4. 6.2.2 Global Transcranial Magnetic Stimulators (TMS) Sales by Region (2027-2032)
  5. 6.3 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Region (2027-2032)
  9. 6.5 Global Transcranial Magnetic Stimulators (TMS) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Transcranial Magnetic Stimulators (TMS) Sales Value (2021-2032)
  12. 6.6.2 North America Transcranial Magnetic Stimulators (TMS) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Transcranial Magnetic Stimulators (TMS) Sales Value (2021-2032)
  15. 6.7.2 Europe Transcranial Magnetic Stimulators (TMS) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Transcranial Magnetic Stimulators (TMS) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Transcranial Magnetic Stimulators (TMS) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Transcranial Magnetic Stimulators (TMS) Sales Value (2021-2032)
  21. 6.9.2 South America Transcranial Magnetic Stimulators (TMS) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Transcranial Magnetic Stimulators (TMS) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Transcranial Magnetic Stimulators (TMS) Sales Value Share by Country, 2025 VS 2032
7 Transcranial Magnetic Stimulators (TMS) Country-level Sales and Value Analysis
  1. 7.1 Global Transcranial Magnetic Stimulators (TMS) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Transcranial Magnetic Stimulators (TMS) Sales by Country (2021-2032)
  4. 7.3.1 Global Transcranial Magnetic Stimulators (TMS) Sales by Country (2021-2026)
  5. 7.3.2 Global Transcranial Magnetic Stimulators (TMS) Sales by Country (2027-2032)
  6. 7.4 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Transcranial Magnetic Stimulators (TMS) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Transcranial Magnetic Stimulators (TMS) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Transcranial Magnetic Stimulators (TMS) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Transcranial Magnetic Stimulators (TMS) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yiruide
  2. 8.1.1 Yiruide Company Information
  3. 8.1.2 Yiruide Business Overview
  4. 8.1.3 Yiruide Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Yiruide Transcranial Magnetic Stimulators (TMS) Product Portfolio
  6. 8.1.5 Yiruide Recent Developments
  7. 8.2 Neuronetics
  8. 8.2.1 Neuronetics Company Information
  9. 8.2.2 Neuronetics Business Overview
  10. 8.2.3 Neuronetics Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Neuronetics Transcranial Magnetic Stimulators (TMS) Product Portfolio
  12. 8.2.5 Neuronetics Recent Developments
  13. 8.3 Magstim
  14. 8.3.1 Magstim Company Information
  15. 8.3.2 Magstim Business Overview
  16. 8.3.3 Magstim Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Magstim Transcranial Magnetic Stimulators (TMS) Product Portfolio
  18. 8.3.5 Magstim Recent Developments
  19. 8.4 Brainsway
  20. 8.4.1 Brainsway Company Information
  21. 8.4.2 Brainsway Business Overview
  22. 8.4.3 Brainsway Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Brainsway Transcranial Magnetic Stimulators (TMS) Product Portfolio
  24. 8.4.5 Brainsway Recent Developments
  25. 8.5 MagVenture
  26. 8.5.1 MagVenture Company Information
  27. 8.5.2 MagVenture Business Overview
  28. 8.5.3 MagVenture Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 MagVenture Transcranial Magnetic Stimulators (TMS) Product Portfolio
  30. 8.5.5 MagVenture Recent Developments
  31. 8.6 eNeura
  32. 8.6.1 eNeura Company Information
  33. 8.6.2 eNeura Business Overview
  34. 8.6.3 eNeura Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 eNeura Transcranial Magnetic Stimulators (TMS) Product Portfolio
  36. 8.6.5 eNeura Recent Developments
  37. 8.7 Remed
  38. 8.7.1 Remed Company Information
  39. 8.7.2 Remed Business Overview
  40. 8.7.3 Remed Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Remed Transcranial Magnetic Stimulators (TMS) Product Portfolio
  42. 8.7.5 Remed Recent Developments
  43. 8.8 Neurosoft
  44. 8.8.1 Neurosoft Company Information
  45. 8.8.2 Neurosoft Business Overview
  46. 8.8.3 Neurosoft Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Neurosoft Transcranial Magnetic Stimulators (TMS) Product Portfolio
  48. 8.8.5 Neurosoft Recent Developments
  49. 8.9 Dr. Langer Medical
  50. 8.9.1 Dr. Langer Medical Company Information
  51. 8.9.2 Dr. Langer Medical Business Overview
  52. 8.9.3 Dr. Langer Medical Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Dr. Langer Medical Transcranial Magnetic Stimulators (TMS) Product Portfolio
  54. 8.9.5 Dr. Langer Medical Recent Developments
  55. 8.10 Nexstim
  56. 8.10.1 Nexstim Company Information
  57. 8.10.2 Nexstim Business Overview
  58. 8.10.3 Nexstim Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Nexstim Transcranial Magnetic Stimulators (TMS) Product Portfolio
  60. 8.10.5 Nexstim Recent Developments
  61. 8.11 MAG & More
  62. 8.11.1 MAG & More Company Information
  63. 8.11.2 MAG & More Business Overview
  64. 8.11.3 MAG & More Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 MAG & More Transcranial Magnetic Stimulators (TMS) Product Portfolio
  66. 8.11.5 MAG & More Recent Developments
  67. 8.12 EB Neuro
  68. 8.12.1 EB Neuro Company Information
  69. 8.12.2 EB Neuro Business Overview
  70. 8.12.3 EB Neuro Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 EB Neuro Transcranial Magnetic Stimulators (TMS) Product Portfolio
  72. 8.12.5 EB Neuro Recent Developments
  73. 8.13 Jiangxi Brain Modulate Technology Development Co., LTD
  74. 8.13.1 Jiangxi Brain Modulate Technology Development Co., LTD Company Information
  75. 8.13.2 Jiangxi Brain Modulate Technology Development Co., LTD Business Overview
  76. 8.13.3 Jiangxi Brain Modulate Technology Development Co., LTD Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Jiangxi Brain Modulate Technology Development Co., LTD Transcranial Magnetic Stimulators (TMS) Product Portfolio
  78. 8.13.5 Jiangxi Brain Modulate Technology Development Co., LTD Recent Developments
  79. 8.14 VISHEE
  80. 8.14.1 VISHEE Company Information
  81. 8.14.2 VISHEE Business Overview
  82. 8.14.3 VISHEE Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 VISHEE Transcranial Magnetic Stimulators (TMS) Product Portfolio
  84. 8.14.5 VISHEE Recent Developments
  85. 8.15 YINGCHI
  86. 8.15.1 YINGCHI Company Information
  87. 8.15.2 YINGCHI Business Overview
  88. 8.15.3 YINGCHI Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 YINGCHI Transcranial Magnetic Stimulators (TMS) Product Portfolio
  90. 8.15.5 YINGCHI Recent Developments
  91. 8.16 Sichuan Junjian Wanfeng Medical Devices Co., Ltd.
  92. 8.16.1 Sichuan Junjian Wanfeng Medical Devices Co., Ltd. Company Information
  93. 8.16.2 Sichuan Junjian Wanfeng Medical Devices Co., Ltd. Business Overview
  94. 8.16.3 Sichuan Junjian Wanfeng Medical Devices Co., Ltd. Transcranial Magnetic Stimulators (TMS) Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Sichuan Junjian Wanfeng Medical Devices Co., Ltd. Transcranial Magnetic Stimulators (TMS) Product Portfolio
  96. 8.16.5 Sichuan Junjian Wanfeng Medical Devices Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Transcranial Magnetic Stimulators (TMS) Value Chain Analysis
  2. 9.1.1 Transcranial Magnetic Stimulators (TMS) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Transcranial Magnetic Stimulators (TMS) Sales Mode & Process
  6. 9.2 Transcranial Magnetic Stimulators (TMS) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Transcranial Magnetic Stimulators (TMS) Distributors
  9. 9.2.3 Transcranial Magnetic Stimulators (TMS) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research